share_log

HC Wainwright & Co. Reiterates Buy on Matinas BioPharma Hldgs, Maintains $3 Price Target

Benzinga Real-time News ·  Jan 31, 2023 19:11

HC Wainwright & Co. analyst Andrew Fein reiterates Matinas BioPharma Hldgs (AMEX:MTNB) with a Buy and maintains $3 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment